Efficacy and safety of ultrasound-guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma in patients aged 55 years or older: a retrospective study

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Kitahara CS, Brenner AV. Thyroid cancer. New York (NY): Oxford University Press, 2018.
   Google Scholar
• Sanabria A, Kowalski LP, Shah JP, et al. Growing incidence of thyroid carcinoma in recent years: factors underlying overdiagnosis. Head Neck. 2018;40(4):855–866.
   PubMed Web of Science ®Google Scholar
• Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.
   PubMed Web of Science ®Google Scholar
• Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg. 2014;140(4):317–322.
   PubMed Web of Science ®Google Scholar
• Sanabria A. Experience with active surveillance of thyroid low-risk carcinoma in a developing country. Thyroid. 2020;30(7):985–991.
   PubMed Web of Science ®Google Scholar
• Sugitani I, Ito Y, Takeuchi D, et al. Indications and strategy for active surveillance of adult low-risk papillary thyroid microcarcinoma: consensus statements from the Japan Association of Endocrine Surgery task force on management for papillary thyroid microcarcinoma. Thyroid. 2021;31(2):183–192.
   PubMed Web of Science ®Google Scholar
• Pitoia F, Smulever A. Active surveillance in low risk papillary thyroid carcinoma. World J Clin Oncol. 2020;11(6):320–336.
   PubMed Web of Science ®Google Scholar
• Brito JP, Hay ID, Morris JC. Low risk papillary thyroid cancer. BMJ. 2014;348:g3045.
   PubMed Web of Science ®Google Scholar
• Oh HS, Ha J, Kim HI, et al. Active surveillance of low-risk papillary thyroid microcarcinoma: a multi-center cohort study in Korea. Thyroid. 2018;28(12):1587–1594.
   PubMed Web of Science ®Google Scholar
• Wrenn SM, Wang TS, Toumi A, et al. Practice patterns for surgical management of low-risk papillary thyroid cancer from 2014 to 2019: a CESQIP analysis. Am J Surg. 2021;221(2):448–454.
   PubMed Web of Science ®Google Scholar
• Zhang M, Tufano RP, Russell JO, et al. Ultrasound-guided radiofrequency ablation versus surgery for low-risk papillary thyroid microcarcinoma: results of over 5 years’ follow-up. Thyroid. 2020;30(3):408–417.
   PubMed Web of Science ®Google Scholar
• Koshkina A, Fazelzad R, Sugitani I, et al. Association of patient age with progression of low-risk papillary thyroid carcinoma under active surveillance: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg. 2020;146(6):552–560.
   PubMed Web of Science ®Google Scholar
• Cho SJ, Baek SM, Lim HK, et al. Long-term follow-up results of ultrasound-guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma: more than 5-year follow-up for 84 tumors. Thyroid. 2020;30(12):1745–1751.
   PubMed Web of Science ®Google Scholar
• Chung SR, Baek JH, Choi YJ, et al. Longer-term outcomes of radiofrequency ablation for locally recurrent papillary thyroid cancer. Eur Radiol. 2019;29(9):4897–4903.
   PubMed Web of Science ®Google Scholar
• Ha EJ, Baek JH, Lee JH, et al. Radiofrequency ablation of benign thyroid nodules does not affect thyroid function in patients with previous lobectomy. Thyroid. 2013;23(3):289–293.
   PubMed Web of Science ®Google Scholar
• Hamidi O, Callstrom MR, Lee RA, et al. Outcomes of radiofrequency ablation therapy for large benign thyroid nodules: a mayo clinic case series. Mayo Clin Proc. 2018;93(8):1018–1025.
   PubMed Web of Science ®Google Scholar
• Lee GM, You JY, Kim HY, et al. Successful radiofrequency ablation strategies for benign thyroid nodules. Endocrine. 2019;64(2):316–321.
   PubMed Web of Science ®Google Scholar
• Choi Y, Jung SL, Bae JS, et al. Comparison of efficacy and complications between radiofrequency ablation and repeat surgery in the treatment of locally recurrent thyroid cancers: a single-center propensity score matching study. Int J Hyperthermia. 2019;36:359–367.
   PubMed Web of Science ®Google Scholar
• Ito Y, Miyauchi A, Kihara M, et al. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid. 2014;24(1):27–34.
   PubMed Web of Science ®Google Scholar
• Nilubol N, Kebebew E. Should small papillary thyroid cancer be observed? A population-based study. Cancer. 2015;121(7):1017–1024.
   PubMed Web of Science ®Google Scholar
• Lin W-C, Kan N-N, Chen H-L, et al. Efficacy and safety of single-session radiofrequency ablation for benign thyroid nodules of different sizes: a retrospective study. Int J Hyperthermia. 2020;37(1):1082–1089.
   PubMed Web of Science ®Google Scholar
• Trimboli P, Castellana M, Sconfienza LM, et al. Efficacy of thermal ablation in benign non-functioning solid thyroid nodule: a systematic review and meta-analysis. Endocrine. 2020;67(1):35–43.
   PubMed Web of Science ®Google Scholar
• Kong QF, Lv B, Wang B, et al. Association of von Willebrand factor (vWF) expression with lymph node metastasis and hemodynamics in papillary thyroid carcinoma. Eur Rev Med Pharmacol Sci. 2020;24(5):2564–2571.
   PubMed Web of Science ®Google Scholar
• Yan L, Luo Y, Xiao J, et al. Non-enhanced ultrasound is not a satisfactory modality for measuring necrotic ablated volume after radiofrequency ablation of benign thyroid nodules: a comparison with contrast-enhanced ultrasound. Euro Radiol. 2020. DOI:https://doi.org/10.1007/s00330-020-07398-0
   Web of Science ®Google Scholar
• Ding M, Tang X, Cui D, et al. Clinical outcomes of ultrasound-guided radiofrequency ablation for the treatment of primary papillary thyroid microcarcinoma. Clin Radiol. 2019;74(9):712–717.
   PubMed Web of Science ®Google Scholar
• Cesareo R, Pacella CM, Pasqualini V, et al. Laser ablation versus radiofrequency ablation for benign non-functioning thyroid nodules: six-month results of a randomized, parallel, open-label trial (Lara Trial). Thyroid. 2020;30(6):847–856.
   PubMed Web of Science ®Google Scholar
• Sim JS, Baek JH, Cho W. Initial ablation ratio: quantitative value predicting the therapeutic success of thyroid radiofrequency ablation. Thyroid. 2018;28(11):1443–1449.
   PubMed Web of Science ®Google Scholar
• Choi Y, Jung SL. Efficacy and safety of thermal ablation techniques for the treatment of primary papillary thyroid microcarcinoma: a systematic review and meta-analysis. Thyroid. 2020;30(5):720–731.
   PubMed Web of Science ®Google Scholar
• Wilhelm S. Evaluation of thyroid incidentaloma. Surg Clin North Am. 2014;94(3):485–497.
   PubMed Web of Science ®Google Scholar
• Miyauchi A, Ito Y, Oda H. Insights into the management of papillary microcarcinoma of the thyroid. Thyroid. 2018;28(1):23–31.
   PubMed Web of Science ®Google Scholar
• Lan Y, Luo Y, Zhang M, et al. Quality of life in papillary thyroid microcarcinoma patients undergoing radiofrequency ablation or surgery: a comparative study. Front Endocrinol. 2020;11:249.
   PubMed Web of Science ®Google Scholar
• Yuan J, Li J, Chen X, et al. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma. Bull Cancer. 2017;104(6):516–523.
   PubMed Web of Science ®Google Scholar
• Ahmadi S, Gonzalez JM, Talbott M, et al. Patient preferences around extent of surgery in low-risk thyroid cancer: a discrete choice experiment. Thyroid. 2020;30(7):1044–1052.
   PubMed Web of Science ®Google Scholar
• Krajewska J, Kukulska A, Oczko-Wojciechowska M, et al. Early diagnosis of low-risk papillary thyroid cancer results rather in overtreatment than a better survival. Front Endocrinol. 2020;11:571421.
   PubMed Web of Science ®Google Scholar
• Alobuia W, Gillis A, Kebebew E. Contemporary management of anaplastic thyroid cancer. Curr Treat Options Oncol. 2020;21(10):78.
   PubMed Web of Science ®Google Scholar
• Hegedus L, Frasoldati A, Negro R, et al. European Thyroid Association survey on use of minimally invasive techniques for thyroid nodules. Eur Thyroid J. 2020;9(4):194–204.
   PubMed Web of Science ®Google Scholar
• Han ZY, Dou JP, Cheng ZG, et al. Efficacy and safety of percutaneous ultrasound-guided microwave ablation for cervical metastatic lymph nodes from papillary thyroid carcinoma. Int J Hyperthermia. 2020;37(1):971–975.
   PubMed Web of Science ®Google Scholar
• Wang L, Ge M, Xu D, et al. Ultrasonography-guided percutaneous radiofrequency ablation for cervical lymph node metastasis from thyroid carcinoma. J Can Res Ther. 2014;10(7):144–149.
   Web of Science ®Google Scholar
• Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14(3):199–208.
   PubMed Web of Science ®Google Scholar
• Yan L, Lan Y, Xiao J, et al. Long-term outcomes of radiofrequency ablation for unifocal low-risk papillary thyroid microcarcinoma: a large cohort study of 414 patients. Eur Radiol. 2021;31(2):685–694.
   PubMed Web of Science ®Google Scholar
• Megwalu UC. Observation versus thyroidectomy for papillary thyroid microcarcinoma in the elderly. J Laryngol Otol. 2017;131(2):173–176.
   PubMed Web of Science ®Google Scholar
• Lan Y, Jin Z, Zhang Y, et al. Factors associated with health-related quality of life in papillary thyroid microcarcinoma patients undergoing radiofrequency ablation: a cross-sectional prevalence study. Int J Hyperthermia. 2020;37(1):1174–1181.
   PubMed Web of Science ®Google Scholar